Search results for "MVA"
showing 9 items of 89 documents
Simvastatin in vitiligo: an update with recent review of the literature.
2021
Patients with vitiligo often seek medical attention, as it diminishes their quality of life resulting in significant morbidity. Several topical and systemic therapies are in vogue targeting the immunological aspect of this disease, but results are often unsatisfactory, and complete cure remains elusive. Recently, simvastatin, a 3-hydroxy-3-methylyglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, is being evaluated for vitiligo management because of its multimodal action, easy availability, and low cost. The proposed multimodal actions range from anti-inflammatory, antioxidant, to immunomodulatory properties which may be of therapeutic benefit in vitiligo patients. The authors intend to eva…
The addition of simvastatin administration to cold storage solution of explanted whole liver grafts for facing ischemia/reperfusion injury in an area…
2018
Abstract Background Liver transplantation is the best treatment for end-stage liver disease. The interruption of the blood supply to the donor liver during cold storage damages the liver, affecting how well the liver will function after transplant. The drug Simvastatin may help to protect donor livers against this damage and improve outcomes for transplant recipients. The aim of this study is to evaluate the benefits of treating the donor liver with Simvastatin compared with the standard transplant procedure. Patient and methods We propose a prospective, double-blinded, randomized phase 2 study of 2 parallel groups of eligible adult patients. We will compare 3-month, 6-month, and 12-month g…
Drug Evaluation: The Combination of Fenofibrate and Simvastatin for the Treatment of Dyslipidemia: When and for Whom?
2015
Simvastatin and fenofibrate are the most frequently co-prescribed drugs for the treatment of dyslipidemia, manifesting beneficial effects on non-lipid parameters as well. The combination of these two drugs has been shown to increase success in the management of combined hyperlipidemia. Their different mechanism of action allows for the targeting of two types of lipid abnormalities: increased cholesterol and atherogenic dyslipidemia. Clinical studies have demonstrated that statin and fibrate combination therapy is effective in improving multiple lipid abnormalities, that may further decrease overall cardiovascular (CV) risk of patients with combined dyslipidemia. However, the clinical use of…
Rational for statin use in psoriatic patients
2013
Psoriasis represents a common skin disease which is clinically manifested by chronic cutaneous lesions. It has been observed that psoriasis is associated with an increased risk of cardiovascular diseases, which is contributed to the inappropriate lipid metabolism. Statins are commonly used in clinical practice to lower cholesterol concentration and, accordingly, decrease the individual risk of developing a cardiovascular episode. There have been reports that statin administration could also result in better management of psoriasis. The observed beneficial effects are contributed to the effects on lipid metabolism, including that in skin, as well as anti-inflammatory and immunomodulatory pro…
Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia
1995
SummaryThromboxane (Tx) A2 biosynthesis is enhanced in the majority of patients with type IIa hypercholesterolemia. Because blood clotting activation is an important component of the inflammatory response, involved in the initiation and progression of atherosclerotic plaques, we have investigated TxA2 biosynthesis, neutrophil activation and thrombin generation in 24 patients with type IIa hypercholesterolemia.Urinary 11-dehydro-TxB2, was significantly higher (p =0.0001) in patients than in 24 sex- and age matched healthy subjects. Similarly, prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complexes and plasma elastase were significantly higher in patients than incontrols. Urinary…
Helsekommunikasjon som skreddersøm : en analyse av samvalgsverktøy og av helsepersonells holdninger til bruk av samvalgsverktøy
2016
Masteroppgave samfunnskommunikasjon- Universitetet i Agder, 2016 Pasientinvolvering er et hett tema i dagens helse-Norge. Pasientene er mer aktive, krever mer informasjon og mer bestemmelsesrett enn tidligere. Denne oppgaven retter fokus mot hvordan helsepersonell opplever denne endringen. I studien undersøkes det hvordan metoden samvalg med bruk av digitalt samvalgsverktøy påvirker helsepersonells måte å kommunisere med pasienter på. Både hvilke muligheter og utfordringer det digitale beslutningsverktøyet gir for kommunikasjonen med pasienter, og hvilke holdninger helsepersonell har knyttet til dette vil undersøkes. For å belyse problemstillingen gis det et teoretisk rammeverk knyttet til …
Kāda biomasas gazifikācijas modeļa skaitliskā analīze
2017
Šajā darbā tiek pētīts gazifikācijas procesa matemātiskais modelis. Tiek analizēta siltumapmaiņas reakcijas vienādojumu sistēma, konstruēts tās matemātiskais modelis un izpētīti raksti par gazifikācijas norises procesiem.